UNITED THERAPEUTICS Corp Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • UNITED THERAPEUTICS Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$93.8M, a 91.2% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$1.25B, a 10445% decline from 2023.
  • UNITED THERAPEUTICS Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$11.9M, a 116% decline from 2022.
  • UNITED THERAPEUTICS Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $75.4M, a 68.3% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

UNITED THERAPEUTICS Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$93.8M +$974M +91.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-30
Q1 2024 -$1.07B -$1.12B -2298% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-30
Q1 2023 $48.6M +$59.6M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q1 2022 -$11M -$21.1M -209% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 $10.1M +$60.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$50.2M -$859M -106% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q1 2019 $809M +$799M +7533% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 $10.6M -$23.8M -69.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q1 2017 $34.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q1 2012 $2.13M -$15.8M -88.1% Jan 1, 2012 Mar 31, 2012 10-Q 2012-04-26
Q1 2011 $18M -$29.1M -61.9% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-26
Q1 2010 $47.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-28

UNITED THERAPEUTICS Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.25B -$1.24B -10445% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-26
2023 -$11.9M -$87.3M -116% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-26
2022 $75.4M +$30.6M +68.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-26
2021 $44.8M +$61.7M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 -$16.9M -$628M -103% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-22
2019 $611M +$605M +9602% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $6.3M -$37M -85.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $43.3M +$541M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
2016 -$498M -$50.7M -11.3% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$447M Jan 1, 2015 Dec 31, 2015 10-K 2018-02-21
2012 -$169M +$48.9M +22.4% Jan 1, 2012 Dec 31, 2012 10-K 2013-02-26
2011 -$218M -$365M -249% Jan 1, 2011 Dec 31, 2011 10-K 2013-02-26
2010 $147M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.